TickerFacts.

Acadia Pharmaceuticals Inc (ACAD): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$982.51M
Year ended 2025-12-31
$1.04B
Trailing 12 months to 2026-06-30
+24.7%
3-year compound annual growth
2016-12-31: $14.25M2017-12-31: $115.82M2018-12-31: $211.43M2019-12-31: $327.73M2020-12-31: $431.54M2021-12-31: $473.30M2022-12-31: $507.07M2023-12-31: $684.80M2024-12-31: $875.96M2025-12-31: $982.51M$982.51M
2016-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$982.51M+12.2%2026-02-26, From 2025-01-01
2024-12-31$875.96M+27.9%2026-02-26, From 2024-01-01
2023-12-31$684.80M+35.1%2024-02-28, From 2023-01-01
2022-12-31$507.07M+7.1%2024-02-28, From 2022-01-01
2021-12-31$473.30Mn/c2023-02-28, From 2021-01-01
2020-12-31$431.54M+31.7%2022-03-01, From 2020-01-01
2019-12-31$327.73M+55.0%2021-02-25, From 2019-01-01
2018-12-31$211.43M+82.5%2020-02-27, From 2018-01-01
2017-12-31$115.82M+712.7%2019-02-27, From 2017-01-01
2016-12-31$14.25Mn/a2018-02-27, From 2016-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Acadia Pharmaceuticals Inc (ACAD)2025-12-31$982.51M+12.2%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$595.58M-6.1%
Indivior Pharmaceuticals, Inc. (INDV)2025-12-31$994.00M+3.9%
Harmony Biosciences Holdings, Inc. (HRMY)2025-12-31$670.11M+20.1%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$463.26M+22.8%
Alkermes plc. (ALKS)2025-12-31$1.28B-2.5%
Phibro Animal Health Corp (PAHC)2026-06-30$512.51M+28.1%
Emergent BioSolutions Inc. (EBS)2025-12-31$416.70M+15.0%
Pacira BioSciences, Inc. (PCRX)2025-12-31$576.66M+8.7%

Compare ACAD, PBH, INDV, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗